Article Versions Notes

Malebari AM, Ibrahim TS, Salem IM, Salama I, Khayyat AN, Mostafa SM, El-Sabbagh OI, Darwish KM. The Anticancer Activity for the Bumetanide-Based Analogs via Targeting the Tumor-Associated Membrane-Bound Human Carbonic Anhydrase-IX Enzyme. Pharmaceuticals. 2020; 13(9):252. https://doi.org/10.3390/ph13090252

Malebari, Azizah M., Tarek S. Ibrahim, Ibrahim M. Salem, Ismail Salama, Ahdab N. Khayyat, Samia M. Mostafa, Osama I. El-Sabbagh, and Khaled M. Darwish. 2020. "The Anticancer Activity for the Bumetanide-Based Analogs via Targeting the Tumor-Associated Membrane-Bound Human Carbonic Anhydrase-IX Enzyme" Pharmaceuticals 13, no. 9: 252. https://doi.org/10.3390/ph13090252

Malebari, A. M., Ibrahim, T. S., Salem, I. M., Salama, I., Khayyat, A. N., Mostafa, S. M., El-Sabbagh, O. I., & Darwish, K. M. (2020). The Anticancer Activity for the Bumetanide-Based Analogs via Targeting the Tumor-Associated Membrane-Bound Human Carbonic Anhydrase-IX Enzyme. Pharmaceuticals, 13(9), 252. https://doi.org/10.3390/ph13090252